New RNA Regulatory Network Identified in Colorectal Cancer Progression and Immune Response
Researchers have identified a key RNA-driven regulatory network that influences colorectal cancer progression and immune response, offering new therapeutic targets to improve treatment resistance. Learn more about this groundbreaking study.
Recent research led by Prof. Gu Hongcang and Zhang Fan at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has uncovered a crucial RNA-driven regulatory network influencing colorectal cancer (CRC) development and immune system interaction. Through comprehensive multi-omics analysis—integrating transcriptomic, proteomic, and metabolomic data—scientists identified key molecular alterations distinguishing CRC tissues from normal counterparts, including 1,394 differentially expressed long non-coding RNAs (lncRNAs), 2,788 mRNAs, 548 proteins, and 91 metabolites.
Among these, a particular lncRNA named lncRNA 60967.1 stood out as a central regulator. It was significantly downregulated in CRC cell lines and patient samples. Functional studies demonstrated that restoring lncRNA 60967.1 reactivates the tumor suppressor gene PLCD4 and increases all-trans retinoic acid (ATRA) levels, which in turn promotes apoptosis through interferon gamma pathways. This enhancement of immune responses partially mitigates the resistance of CRC cells to immune attack.
In vivo experiments in mouse models showed that overexpression of lncRNA 60967.1 boosted immune cell infiltration into tumors and significantly inhibited tumor growth, especially when combined with anti-PD-1 immunotherapy. These findings suggest that lncRNA 60967.1 influences both tumor progression and immune response mechanisms, presenting a promising therapeutic target.
The research, published in Molecular Cancer, highlights the importance of the newly identified lncRNA 60967.1–PLCD4–ATRA axis. Targeting this pathway could help overcome resistance in CRC treatments and improve immunotherapy efficacy. This discovery advances our understanding of CRC's molecular complexity and opens new avenues for precision medicine strategies in combating this disease.
Source: https://medicalxpress.com/news/2025-07-uncovers-key-rna-driven-network.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Research Links Rugby Participation to Increased Risk of Dementia
A new study from the University of Auckland reveals that former male rugby players face an increased risk of dementia, highlighting the long-term neurological effects of collision sports and the importance of safety measures.
Higher Rates of Leg Amputation Due to Arterial Disease in Disadvantaged Communities
A new study reveals that leg amputations caused by arterial disease are four times more common in disadvantaged communities in England, highlighting significant health inequalities and the urgent need for targeted prevention efforts.
OpenAI Launches HealthBench Dataset to Advance AI in Healthcare
OpenAI has launched HealthBench, a new dataset to evaluate and improve AI models in healthcare, featuring thousands of conversations assessed by medical experts to ensure safety and reliability.
Innovative Healthcare Partnerships Reduce Emergency Room Visits Among Seniors
A new community-based program connecting seniors with volunteers has significantly reduced emergency room visits and loneliness among older adults, demonstrating the impact of social support in healthcare.